Effect of a kind of fermented milk on metabolic syndrome in adolescents

Clinical trial on the effect of kind of fermented milk on cardiometabolic risk factors, insulin resistance, some incretin hormones and related immunologic/inflammatory markers in 11-18-years-old adolescents with metabolic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201508081202N2

Enrollment

Registered

2015-09-19

Start date

2015-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome.

Interventions

Intervention 1: Intervention: 250 cc fermented camel milk daily for 2 months. Intervention 2: Control:250-500 cc fermented cow milk daily for two months.

Treatment - Other

Intervention: 250 cc fermented camel milk daily for 2 months

Control:250-500 cc fermented cow milk daily for two months

Eligibility

Sex/Gender

All

Age

11 Years to 18 Years

Inclusion criteria

Inclusion criteria: Major inclusion criteria: 11-18 years old; both genders; Iranian nationality; diagnosed with Metabolic syndrome. Major exclusion criteria: other diseases; not consuming milk product for more than 3 consecutive or 7 intermittent days; side effects like allergic reactions.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Selected cardiometabolic risk factors. Timepoint: During the week before and the week after 2 months intervention. Method of measurement: Blood biochemistry and physical examinations.	—

Secondary

Measure	Time frame
Insulin resistance level. Timepoint: During the week before and the week after 2 months intervention. Method of measurement: Blood test and calculation.;Incretine hormones level. Timepoint: During the week before and the week after 2 months intervention. Method of measurement: Blood test.;Some immuno/inflammatory biomarkers. Timepoint: During the week before and the week after 2 months intervention. Method of measurement: Blood test.	—

Measure

Time frame

Insulin resistance level. Timepoint: During the week before and the week after 2 months intervention. Method of measurement: Blood test and calculation.;Incretine hormones level. Timepoint: During the week before and the week after 2 months intervention. Method of measurement: Blood test.;Some immuno/inflammatory biomarkers. Timepoint: During the week before and the week after 2 months intervention. Method of measurement: Blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Zahra Fallah

Isfahan University of Medical Sciences

z_fallah@mail.mui.ac.ir+98 31 3792 3321

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026